Susquehanna International Group, LLP Entera Bio Ltd. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Entera Bio Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 34,766 shares of ENTX stock, worth $68,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,766
Previous 38,399
9.46%
Holding current value
$68,141
Previous $79,000
25.32%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ENTX
# of Institutions
22Shares Held
10.2MCall Options Held
31KPut Options Held
100-
Knoll Capital Management, LLC Miami, FL5.88MShares$11.5 Million6.68% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.7MShares$5.29 Million0.01% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY599KShares$1.17 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT440KShares$861,6780.1% of portfolio
-
Northern Trust Corp Chicago, IL199KShares$389,7080.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $56.5M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...